PLCD3 connects to PI3K (Phosphatidylinositol-4,5-bisphosphate 3-kinase) and EGFR, which are both critical in GBM, with PI3K signaling exhibiting heterogeneous signaling that is the subject of ongoing investigation [58,59]. The gene discussed is EGFR; the disease is glioblastoma.